retatrutide explained 💠 (Reta) is a synthetic peptide-based drug composed of 39 amino acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases Retatrutide Guide 2023: Weight Loss,

The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]

Nature Reviews Gastroenterology & Hepatology , 16(1), 3556

Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems

Obesity doctors and researchers say within several years, they expect treatment will be more customized to meet the needs of each patient